Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of fluorinated organic compounds that exhibit enhanced metabolic stability and bioavailability. Its structure supports the creation of active ingredients in drugs targeting central nervous system disorders and anti-inflammatory agents. The presence of both hydroxyl and fluoromethyl groups allows for selective functionalization in multi-step organic reactions, making it valuable in medicinal chemistry research and development.